Suppr超能文献

产生 Aβ42 的最长淀粉样β前体蛋白细胞内结构域形成β-折叠结构单体,这些单体自组装并被胰岛素降解酶蛋白水解。

The Longest Amyloid-β Precursor Protein Intracellular Domain Produced with Aβ42 Forms β-Sheet-Containing Monomers That Self-Assemble and Are Proteolyzed by Insulin-Degrading Enzyme.

机构信息

Carlson School of Chemistry and Biochemistry , Clark University , 950 Main Street , Worcester , Massachusetts 01610 , United States.

出版信息

ACS Chem Neurosci. 2018 Dec 19;9(12):2892-2897. doi: 10.1021/acschemneuro.8b00305. Epub 2018 Aug 3.

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease resulting in dementia. It is characterized pathologically by extracellular amyloid plaques composed mainly of deposited Aβ42 and intracellular neurofibrillary tangles formed by hyperphosphorylated tau protein. Recent clinical trials targeting Aβ have failed, suggesting that other polypeptides produced from the amyloid-β precursor protein (APP) may be involved in AD. An attractive polypeptide is AICD57, the longest APP intracellular domain (AICD) coproduced with Aβ42. Here, we show that AICD57 forms micelle-like assemblies that are proteolyzed by insulin-degrading enzyme (IDE), indicating that AICD57 monomers are in dynamic equilibrium with AICD57 assemblies. The N-terminal part of AICD57 monomer is not degraded, but its C-terminal part is hydrolyzed, particularly in the YENPTY motif that has been associated with the hyperphosphorylation of tau. Therefore, sustaining IDE activity well into old age holds promise for regulating levels of not only Aβ but also AICD in the aging brain.

摘要

阿尔茨海默病(AD)是最常见的导致痴呆的神经退行性疾病。其病理特征为主要由沉积的 Aβ42 组成的细胞外淀粉样斑块和由过度磷酸化的 tau 蛋白形成的细胞内神经原纤维缠结。最近针对 Aβ 的临床试验失败表明,淀粉样-β 前体蛋白 (APP) 产生的其他多肽可能与 AD 有关。一种有吸引力的多肽是 AICD57,它是与 Aβ42 一起产生的 APP 最长的细胞内结构域 (AICD)。在这里,我们表明 AICD57 形成胶束样组装体,被胰岛素降解酶 (IDE) 蛋白水解,这表明 AICD57 单体与 AICD57 组装体处于动态平衡。AICD57 单体的 N 端部分不会被降解,但 C 端部分被水解,特别是在与 tau 过度磷酸化相关的 YENPTY 基序中。因此,保持 IDE 活性到老年有望调节衰老大脑中不仅 Aβ而且 AICD 的水平。

相似文献

4
beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain.
Pharmacol Res. 2010 Oct;62(4):308-17. doi: 10.1016/j.phrs.2010.05.002. Epub 2010 May 16.
5
Alzheimer's disease.
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
6
7
Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
Neurobiol Dis. 2008 Sep;31(3):442-50. doi: 10.1016/j.nbd.2008.06.001. Epub 2008 Jun 17.
8
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4162-7. doi: 10.1073/pnas.0230450100. Epub 2003 Mar 12.
10
Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Pathol Int. 2017 Apr;67(4):185-193. doi: 10.1111/pin.12520. Epub 2017 Mar 5.

引用本文的文献

1
Exchange Broadening Underlies the Enhancement of IDE-Dependent Degradation of Insulin by Anionic Membranes.
ACS Omega. 2022 Jul 7;7(28):24757-24765. doi: 10.1021/acsomega.2c02747. eCollection 2022 Jul 19.
2
Differential Effects of Polyphenols on Insulin Proteolysis by the Insulin-Degrading Enzyme.
Antioxidants (Basel). 2021 Aug 25;10(9):1342. doi: 10.3390/antiox10091342.

本文引用的文献

1
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.
J Alzheimers Dis. 2018;64(s1):S567-S610. doi: 10.3233/JAD-179941.
2
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease.
Front Neurosci. 2018 Jan 30;12:25. doi: 10.3389/fnins.2018.00025. eCollection 2018.
3
Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease.
Trends Pharmacol Sci. 2018 Jan;39(1):49-58. doi: 10.1016/j.tips.2017.10.008. Epub 2017 Nov 10.
5
Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?
ACS Chem Neurosci. 2017 Jul 19;8(7):1435-1437. doi: 10.1021/acschemneuro.7b00188. Epub 2017 Jun 6.
6
Binding Modes of Thioflavin T on the Surface of Amyloid Fibrils Studied by NMR.
Chemphyschem. 2016 Aug 18;17(16):2461-4. doi: 10.1002/cphc.201600246. Epub 2016 Jun 7.
7
Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
Trends Endocrinol Metab. 2016 Jan;27(1):24-34. doi: 10.1016/j.tem.2015.11.003. Epub 2015 Dec 2.
8
Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles.
J Biol Chem. 2015 Sep 25;290(39):23515-22. doi: 10.1074/jbc.R115.677211. Epub 2015 Aug 21.
10
Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo.
J Biol Chem. 2015 Aug 14;290(33):20044-59. doi: 10.1074/jbc.M115.638205. Epub 2015 Jun 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验